Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
You have a patient safety issue, not a PR issue. The 6 month regulatory reporting timeline is the formal process, not the ethical or legal obligation to act now. Waiting for more data while patients continue to be exposed is criminal negligence exposure, not risk mitigation.Read the full answer
My decision as CEO I would not wait six months. I would treat this as a credible, serious post-marketing safety signal requiring immediate precautionary action, urgent regulator engagement, and public disclosure before the earnings call.Read the full answer